New combo therapy aims to boost lung cancer treatment success
Disease control
Recruiting now
This study tests a new way to give radiation therapy (using PET scans to target smaller areas) along with standard chemo and an immunotherapy drug (durvalumab) for people with stage III lung cancer that cannot be removed by surgery. About 110 adults will be randomly assigned to e…
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated May 11, 2026 20:40 UTC